• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 11/25/14

    • 30-Day SEC Yield1

      1.77%
    • Total Net Assets

      $355.9M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      12/26/2014
  • Portfolio Composition (%)
    as of 11/25/14

    • % of Net Assets
    • Stocks

      100.06
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.06
  • Download All HoldingsAll Holdings (%)as of 11/25/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    358,434
    38,244,90810.75
    Novartis Ag
    NVS US
    367,119
    34,890,9889.80
    Pfizer Inc
    PFE US
    851,143
    25,934,3287.29
    Merck & Co Inc
    MRK US
    337,777
    20,043,6885.63
    Abbvie Inc
    ABBV US
    269,362
    18,332,7785.15
    Bristol-Myers Squibb Co
    BMY US
    301,583
    17,648,6384.96
    Actavis Plc
    ACT US
    65,178
    17,618,2664.95
    Glaxosmithkline Plc
    GSK US
    362,023
    16,754,4244.71
    Novo Nordisk A/S
    NVO US
    372,502
    16,639,6644.68
    Allergan Inc/United States
    AGN US
    77,654
    16,470,4134.63
    Sanofi
    SNY US
    343,944
    16,388,9324.61
    Abbott Laboratories
    ABT US
    359,087
    15,857,2824.46
    Eli Lilly & Co
    LLY US
    230,190
    15,388,2024.32
    Astrazeneca Plc
    AZN US
    206,222
    15,190,3134.27
    Teva Pharmaceutical Industries Ltd
    TEVA US
    232,937
    13,179,5753.70
    Valeant Pharmaceuticals International I
    VRX US
    81,306
    11,769,8573.31
    Shire Plc
    SHPG US
    53,034
    11,265,4823.17
    Mckesson Corp
    MCK US
    53,090
    11,092,6253.12
    Mylan Inc/Pa
    MYL US
    93,342
    5,243,0201.47
    Zoetis Inc
    ZTS US
    119,254
    5,236,4431.47
    Perrigo Co
    PRGO US
    31,452
    4,921,2951.38
    Mallinckrodt Plc
    MNK US
    27,382
    2,489,2980.70
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    30,728
    2,219,1760.62
    Hospira Inc
    HSP US
    36,231
    2,176,7590.61
    Salix Pharmaceuticals Ltd
    SLXP US
    10,533
    1,077,9470.30
    Other/Cash
    -201,200-0.06
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.